Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection

Cancer Science

Volumn 97, Issue 7, 2006, Pages 605-610

  Liu, Angen ^a   Takakuwa, Tetsuya ^a   Luo, Wen Juan ^a   Fujita, Shigeki ^a   Aozasa, Katsuyuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATR PROTEIN; DOUBLE STRANDED DNA; PROTEIN P53; SINGLE STRANDED DNA;

ADULT; AGED; ARTICLE; BIOACCUMULATION; CARCINOGENESIS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA REPAIR; DNA STRAND BREAKAGE; EPSTEIN BARR VIRUS; GENETIC CODE; GENETIC DISORDER; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IONIZING RADIATION; NATURAL KILLER T CELL; NONHUMAN; NOSE TUMOR; PATHOGENESIS; PRIORITY JOURNAL; RNA SPLICING; SAMPLE; T CELL LYMPHOMA; TUMOR CELL LINE; ULTRAVIOLET RADIATION; VIRUS INFECTION;

ALTERNATIVE SPLICING; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHRONIC DISEASE; DISEASE PROGRESSION; DNA; DNA DAMAGE; DNA REPAIR; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MUTATION; NOSE NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 33745953599     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2006.00226.x     Document Type: Article

References (33)

1. Kikuta H, Taguchi Y, Tomizawa K et al. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 1988; 333: 455-7.
2. Jones JF, Shurin S, Abramowsky C et al. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 1988; 318: 733-41.
3. Harabuchi Y, Yamanaka N, Kataura A et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990; 335: 128-30.
4. Ho FC, Srivastava G, Loke SL et al. Presence of Epstein-Barr virus DNA in nasal lymphomas of B- and T-cell type. Hematol Oncol 1990; 8: 271-81.
5. Zhang Y, Nagata H, Ikeuchi T et al. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions. Br J Haematol 2003; 121: 805-14.
6. Wong KF, Zhang YM, Chan JK. Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia - is there a consistent pattern? Leuk Lymphoma 1999; 34: 241-50.
7. Shiloh Y. ATM and related protein kinases: Safeguarding genome integrity. Nat Rev Cancer 2003; 3: 155-68.
8. Tibbetts RS, Cortez D, Brumbaugh KM et al. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev 2000; 14: 2989-3002.
9. Zhou BB, Elledge SJ. The DNA damage response: Putting checkpoints in perspective. Nature 2000; 408: 433-9.
10. Khanna KK, Jackson SP. DNA double-strand breaks: Signaling, repair and the cancer connection. Nat Genet 2001; 27: 247-54.
11. Rouse J, Jackson SP. Interfaces between the detection, signaling, and repair of DNA damage. Science 2002; 297: 547-51.
12. Cliby WA, Roberts CJ, Cimprich KA et al. Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J 1998; 17: 159-69.
13. O'Driscoll M, Ruiz PV, Woods CG, Jeggo PA, Goodship JA. A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat Genet 2003; 33: 497-501.
14. Casper AM, Nghiem P, Arlt MF, Glover TW. ATR regulates fragile site stability. Cell 2002; 111: 779-89.
15. Kagami Y, Nakamura S, Suzuki R et al. Establishment of an IL-2-dependent cell line derived from 'nasal-type' NK/T-cell lymphoma of CD2+, sCD3-, CD3epsilon+, CD56+ phenotype and associated with the Epstein-Barr virus. Br J Haematol 1998; 103: 669-77.
16. Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia 1994; 8: 652-8.
17. Nagata H, Konno A, Kimura N et al. Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus. Blood 2001; 97: 708-13.
18. Yodoi J, Teshigawara K, Nikaido T et al. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol 1985; 134: 1623-30.
19. Yagita M, Huang CL, Umehara H et al. Novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia 2000; 14: 922-30.
20. Matsuo Y, Drexler HG, Takeuchi M, Tanaka M, Orita K. Establishment of the T-cell large granular lymphocyte leukemia cell line MOTN-1 carrying natural killer-cell antigens. Leuk Res 2002; 26: 873-9.
21. Emi N, Abe A, Kasai M et al. CD4- and CD56-positive T-cell line, MTA, established from natural killer-like T-cell leukemia/lymphoma. Int J Hematol 1999; 69: 180-5.
22. Imai S, Sugiura M, Oikawa O et al. Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood 1996; 87: 1446-57.
23. Liu A, Takakuwa T, Fujita S et al. Alterations of DNA damage-response genes ATM and ATR in pyothorax-associated lymphoma. Lab Invest 2005; 85: 436-46.
24. Abbott DW, Freeman ML, Holt JT. Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells. J Natl Cancer Inst 1998; 90: 978-85.
25. Brown EJ, Baltimore D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev 2000; 14: 397-402.
26. De Klein A, Muijtjens M, Van Os R et al. Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice. Curr Biol 2000; 10: 479-82.
27. Lewis KA, Mullany S, Thomas B et al. Heterozygous ATR mutations in mismatch repair-deficient cancer cells have functional significance. Cancer Res 2005; 65: 7091-5.
28. Teruya-Feldstein J, Jaffe ES, Burd PR et al. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood 1997; 90: 4099-105.
29. Menoyo A, Alazzouzi H, Espin E, Armengol M, Yamamoto H, Schwartz S Jr. Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability. Cancer Res 2001; 61: 7727-30.
30. Vassileva V, Millar A, Briollais L, Chapman W, Bapat B. Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability. Cancer Res 2002; 62: 4095-9.
31. Mongiat-Artus P, Miquel C, van der Aa M et al. Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract. Oncogene 2006; 25: 2133-8.
32. Li LS, Kim NG, Kim SH et al. Chromosomal imbalances in the colorectal carcinomas with microsatellite instability. Am J Pathol 2003; 163: 1429-36.
33. Ham MF, Takakuwa T, Luo WJ et al. Impairment of double-strand breaks repair and aberrant splicing of ATM and MRE11 in leukemia-lymphoma cell lines with microsatellite instability. Cancer Sci 2006; 97: 226-34.